MediWound (MDWD) Scheduled to Post Earnings on Tuesday

MediWound (NASDAQ:MDWD) will be announcing its earnings results before the market opens on Tuesday, November 26th. Analysts expect the company to announce earnings of ($0.48) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

MediWound Trading Down 1.7 %

NASDAQ MDWD opened at $16.48 on Friday. The firm has a market capitalization of $177.82 million, a P/E ratio of -7.63 and a beta of 0.83. The firm’s fifty day moving average price is $17.21 and its two-hundred day moving average price is $17.40. MediWound has a 1 year low of $8.41 and a 1 year high of $24.00.

Analyst Ratings Changes

MDWD has been the topic of a number of research analyst reports. HC Wainwright reaffirmed a “buy” rating and issued a $28.00 target price on shares of MediWound in a report on Friday, October 11th. StockNews.com upgraded MediWound to a “sell” rating in a research note on Monday, August 5th.

MediWound Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.